Targeted therapies that neutralize tumour necrosis factor are often able to control the signs
and symptoms of spondyloarthritis. However, recent animal model data and clinical …

Diffuse idiopathic skeletal hyperostosis (DISH) is a well-recognised entity characterised by
calcifications and ossifications of the entheses affecting mainly the spine and peripheral …

Objectives: To evaluate further in a phase III, double blind trial the efficacy of infliximab in
patients with active psoriatic arthritis (PsA), as observed in the smaller IMPACT trial …

Psoriatic arthritis occurs in a subset of psoriasis patients and is therefore commonly
encountered in dermatology practice. Although its exact pathogenesis is unknown, psoriatic …

Therapeutic targets have been defined for axial and peripheral spondyloarthritis (SpA) in
2012, but the evidence for these recommendations was only of indirect nature. These …

Objective: Our aim was to determine whether C-reactive protein (CRP) or erythrocyte
sedimentation rate (ESR) is more appropriate in measuring disease activity in ankylosing …

Introduction The objective was to develop a questionnaire that can be used to calculate a
score reflecting the impact of psoriatic arthritis (PsA) from the patients' perspective: the PsA …

Objective To determine the overall prevalence of spondyloarthropathy (SpA) among patients
with inflammatory bowel disease (IBD)[Crohn's disease (CD) and ulcerative colitis (UC)] …

Objectives. Although clinicians recognize hip involvement, which frequently leads to hip
replacement surgery, as an important feature of AS, data on the epidemiology, nature of the …

Objective To develop new composite disease activity indices for psoriatic arthritis (PsA).
Methods Data from routine clinic visits at multiple centres were collected in a systematic …